Table 1.

Characteristics of patients with EML4-ALK-positive NSCLC and the associated JAK2 and STAT6 protein expression

Case number	Smoking status	Histology (H&E)	pTNM	ALK/P-JAK2/P-STAT6 IHC at primary sites	ALK/P-JAK2/P-STAT6-IHC at metastatic sites
1-147	Non	AD	T2aN2M0	+ / + / +	–/–/–
2-159	Non	Mixed-AD	T1N2M0	+ / ±	+ / ±
3-161	Non	Mixed-AD	T1N2M0	+ / + / +	–/–/–
4-170	Non	Ad + SCC	T2bN2M0	+ / ±	–/–/–
5-177	Non	Mixed -AD	T2aN1M0	+ / + / +	+ / ±
6-184	Yes	Mixed -AD	T2aN1M1	+ / + / +	+ / ±
7-98	Non	Mucinous BAC	T2aN0M0	+ / + / +	/

AD adenocarcinoma, SCC squamous carcinoma, BAC bronchioloalveolar carcinoma, + positive, − negative